Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase 2 Study Testing Two Conditioning Regimen With a Single Prophylaxis of Graft-versus-host Disease by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation

NCT06252870 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT06252870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06252870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase 2 Study Testing Two Conditioning Regimen With a Single Prophylaxis of Graft-versus-host Disease by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation
Lead sponsor
Nantes University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
July 18, 2024
Completion date
July 18, 2028
Enrollment
82 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease, hematologic malignancy